Clearpoint Neuro Stock Buy Hold or Sell Recommendation
| CLPT Stock | USD 12.24 0.13 1.05% |
Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding Clearpoint Neuro is 'Cautious Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Clearpoint Neuro given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Clearpoint Neuro, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Clearpoint Neuro Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Clearpoint Stock please use our How to Invest in Clearpoint Neuro guide. Note, we conduct extensive research on individual companies such as Clearpoint and provide practical buy, sell, or hold advice based on investors' constraints. Clearpoint Neuro. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
Clearpoint |
Execute Clearpoint Neuro Buy or Sell Advice
The Clearpoint recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Clearpoint Neuro. Macroaxis does not own or have any residual interests in Clearpoint Neuro or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Clearpoint Neuro's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Clearpoint Neuro Trading Alerts and Improvement Suggestions
| Clearpoint Neuro had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 23.95 M. Net Loss for the year was (22.09 M) with profit before overhead, payroll, taxes, and interest of 13.53 M. | |
| Clearpoint Neuro currently holds about 45.14 M in cash with (13.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.84. | |
| Clearpoint Neuro has a poor financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: ClearPoint Neuro Inc Shares Up 4.29 percent on Nov 29 |
Clearpoint Neuro Returns Distribution Density
The distribution of Clearpoint Neuro's historical returns is an attempt to chart the uncertainty of Clearpoint Neuro's future price movements. The chart of the probability distribution of Clearpoint Neuro daily returns describes the distribution of returns around its average expected value. We use Clearpoint Neuro price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Clearpoint Neuro returns is essential to provide solid investment advice for Clearpoint Neuro.
| Mean Return | -0.05 | Value At Risk | -3.91 | Potential Upside | 6.76 | Standard Deviation | 3.63 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Clearpoint Neuro historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Clearpoint Stock Institutional Investors
The Clearpoint Neuro's institutional investors refer to entities that pool money to purchase Clearpoint Neuro's securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Legato Capital Management Llc | 2024-09-30 | 159 K | Lane Generational Llc | 2024-09-30 | 157.7 K | Susquehanna International Group, Llp | 2024-09-30 | 151 K | Jane Street Group Llc | 2024-06-30 | 144.1 K | Parsons Capital Management Inc | 2024-09-30 | 139 K | Qube Research & Technologies | 2024-09-30 | 124.5 K | State Street Corp | 2024-09-30 | 105.2 K | Citigroup Inc | 2024-09-30 | 90.6 K | Citadel Advisors Llc | 2024-09-30 | 85.9 K | Vanguard Group Inc | 2024-09-30 | 1.2 M | Essex Investment Management Company, Llc | 2024-09-30 | 463.9 K |
Clearpoint Neuro Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (1.0M) | (25K) | (1.7M) | (4.4M) | 1.2M | 1.3M | |
| Change In Cash | 2.6M | 14.4M | 34.0M | (26.5M) | (4.5M) | (4.3M) | |
| Free Cash Flow | (3.0M) | (8.3M) | (12.9M) | (17.3M) | (14.8M) | (14.0M) | |
| Depreciation | 250.6K | 553K | 692K | 777K | 1.5M | 1.5M | |
| Other Non Cash Items | 729.3K | 893K | 425K | (346K) | 1.2M | 617.3K | |
| Capital Expenditures | 160.2K | 482K | 168K | 1.1M | 1.1M | 1.1M | |
| Net Income | (5.5M) | (6.8M) | (14.4M) | (16.4M) | (22.1M) | (21.0M) | |
| End Period Cash Flow | 5.7M | 20.1M | 54.1M | 27.6M | 23.1M | 13.2M | |
| Investments | (160.2K) | (482K) | (168K) | (9.6M) | 20.9M | 21.9M | |
| Change To Netincome | 799K | 197K | 2.6M | 4.0M | 4.6M | 4.8M |
Clearpoint Neuro Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Clearpoint Neuro or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Clearpoint Neuro's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Clearpoint stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.24 | |
β | Beta against Dow Jones | 1.62 | |
σ | Overall volatility | 3.69 | |
Ir | Information ratio | -0.05 |
Clearpoint Neuro Volatility Alert
Clearpoint Neuro exhibits very low volatility with skewness of -0.03 and kurtosis of 3.02. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Clearpoint Neuro's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Clearpoint Neuro's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Clearpoint Neuro Fundamentals Vs Peers
Comparing Clearpoint Neuro's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Clearpoint Neuro's direct or indirect competition across all of the common fundamentals between Clearpoint Neuro and the related equities. This way, we can detect undervalued stocks with similar characteristics as Clearpoint Neuro or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Clearpoint Neuro's fundamental indicators could also be used in its relative valuation, which is a method of valuing Clearpoint Neuro by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Clearpoint Neuro to competition |
| Fundamentals | Clearpoint Neuro | Peer Average |
| Return On Equity | -0.68 | -0.31 |
| Return On Asset | -0.28 | -0.14 |
| Profit Margin | (0.60) % | (1.27) % |
| Operating Margin | (0.64) % | (5.51) % |
| Current Valuation | 319.76 M | 16.62 B |
| Shares Outstanding | 27.58 M | 571.82 M |
| Shares Owned By Insiders | 7.83 % | 10.09 % |
| Shares Owned By Institutions | 30.53 % | 39.21 % |
| Number Of Shares Shorted | 759.9 K | 4.71 M |
| Price To Earning | (3.36) X | 28.72 X |
| Price To Book | 11.64 X | 9.51 X |
| Price To Sales | 11.10 X | 11.42 X |
| Revenue | 23.95 M | 9.43 B |
| Gross Profit | 13.53 M | 27.38 B |
| EBITDA | (20.99 M) | 3.9 B |
| Net Income | (22.09 M) | 570.98 M |
| Cash And Equivalents | 45.14 M | 2.7 B |
| Cash Per Share | 1.84 X | 5.01 X |
| Total Debt | 13.94 M | 5.32 B |
| Debt To Equity | 0.28 % | 48.70 % |
| Current Ratio | 10.33 X | 2.16 X |
| Book Value Per Share | 1.05 X | 1.93 K |
| Cash Flow From Operations | (13.72 M) | 971.22 M |
| Short Ratio | 2.77 X | 4.00 X |
| Earnings Per Share | (0.69) X | 3.12 X |
| Price To Earnings To Growth | (0.46) X | 4.89 X |
| Target Price | 16.33 | |
| Number Of Employees | 107 | 18.84 K |
| Beta | 1.11 | -0.15 |
| Market Capitalization | 337.64 M | 19.03 B |
| Total Asset | 42.66 M | 29.47 B |
| Retained Earnings | (172.46 M) | 9.33 B |
| Working Capital | 28.74 M | 1.48 B |
Note: Disposition of 4824 shares by Dalessandro Danilo of Clearpoint Neuro at 5.74 subject to Rule 16b-3 [view details]
Clearpoint Neuro Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Clearpoint . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Clearpoint Neuro Buy or Sell Advice
When is the right time to buy or sell Clearpoint Neuro? Buying financial instruments such as Clearpoint Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Clearpoint Neuro in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Munis Funds Thematic Idea Now
Munis Funds
Funds or Etfs that invest in fixed income securities issued by states, cities, and towns as well as other public entities. The Munis Funds theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Munis Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Clearpoint Stock Analysis
When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.